Table 1.
Demographic characteristics, complications, treatment, and outcomes.
Characteristic | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
---|---|---|---|---|
Age (years) | 62 | 63 | 67 | 58 |
Sex | Male | Male | Female | Female |
Occupation | Farmer | Retired | Retired | Farmer |
Cardinal symptom | High fever, chest distress, shortness of breath, dyspnea | Cough, high fever, dyspnea, hemoptysis | High fever, chest distress, dyspnea | High fever, chest pain, cough, chest distress, shortness of breath, abdominal pain |
Underlying conditions | Hypertension | Hypertension, coronary heart disease, COPD, pulmonary heart disease | Hypertension, coronary heart disease, tuberculosis of lymph nodes | Hypertension |
Poultry exposure in the past 2 weeks | Yes | Yes | Yes | Yes |
Septic shock | Yes | Yes | Yes | Yes |
ARDS | Yes | Yes | Yes | Yes |
Acute renal damage | No | Yes | Yes | Yes |
Encephalopathy | No | No | Yes | Yes |
Rhabdomyolysis | No | Yes | No | Yes |
Secondary infections | No | No | Yes | Yes |
Oxygen therapy | Yes | Yes | Yes | Yes |
Extracorporeal membrane oxygenation | No | Yes | Yes | Yes |
Continuous renal-replacement therapy | No | Yes | Yes | Yes |
Antibiotic therapy | Linezolid, imipenem, cilastatin sodium, piperacillin, teicoplanin, moxifloxacin | Linezolid, imipenem, cilastatin sodium, vancomycin, piperacillin, teicoplanin | Linezolid, imipenem, cilastatin sodium, vancomycin, piperacillin, teicoplanin | Imipenem and cilastatin, linezolid, cefoperazone and sulbactam, moxifloxacin |
Antiviral agents | Oseltamivir | Oseltamivir, peramivir | Oseltamivir, peramivir | Oseltamivir |
Steroids | Methylprednisolone | Methylprednisolone | Methylprednisolone | Methylprednisolone |
Intravenous immunoglobulin therapy | Yes | Yes | Yes | Yes |
Duration of hospital stay | 16 days | 7 days | 26 days | 28 days |
Prognosis | Cured | Death | Discharge when H7N9 was negative | Cured |